Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-10 | New | $50,100,000 | $50,100,000 | Equity Only | 06b | SEC link |
| 2024-08-06 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2024-08-06 | New | $750,000 | $750,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Richard Baxter | Director |
| Todd Davis | Director |
| Ezra Friedberg | Director |
| Peter Greenleaf | Director |
| Francis Knuettel | Executive |
| Francis Knuettel Ii | Executive |
| Eric Lang | Executive |
| Richard Malamut | Director |
| Matthew Pauls | Director |
| Scott Plesha | Director, Executive |
| Sai Rangarao | Executive |
| Chia Lin Simmons | Director |